Literature DB >> 3124905

New drugs. Anti-infectives.

R Finch1.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3124905      PMCID： PMC2544778          DOI： 10.1136/bmj.296.6617.261

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  16 in total

1.  The prophylactic use of ticarcillin/clavulanate in the neonate.

Authors:  S B Fayed; A M Sutton; T L Turner; T A McAllister
Journal:  J Antimicrob Chemother       Date:  1987-01       Impact factor: 5.790

Review 2.  The management of near drowning.

Authors:  J Pearn
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-23

3.  Intravenous Augmentin in bacteraemia and severe invasive polymicrobial sepsis.

Authors:  S Mehtar; A P Ball
Journal:  J Antimicrob Chemother       Date:  1985-06       Impact factor: 5.790

4.  A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections.

Authors:  T J Cooper; E Ladusans; P E Williams; V Polychronopoulos; H Gaya; R M Rudd
Journal:  J Antimicrob Chemother       Date:  1985-09       Impact factor: 5.790

5.  Clinical evaluation of cefotetan in the treatment of lower respiratory tract infections.

Authors:  T M Nolen; H L Phillips; H J Hall
Journal:  J Antimicrob Chemother       Date:  1983-01       Impact factor: 5.790

Review 6.  Potential for bleeding with the new beta-lactam antibiotics.

Authors:  F R Sattler; M R Weitekamp; J O Ballard
Journal:  Ann Intern Med       Date:  1986-12       Impact factor: 25.391

7.  Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers.

Authors:  S M Harding; P E Williams; J Ayrton
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

Review 8.  Ciprofloxacin: an overview of adverse experiences.

Authors:  P Ball
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

9.  Clinical, microbiological and pharmacokinetic studies on ofloxacin in acute purulent exacerbations of chronic respiratory disease.

Authors:  F P Maesen; B I Davies; C Baur; C A Sumajow
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

10.  Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa.

Authors:  B E Scully; H C Neu; M F Parry; W Mandell
Journal:  Lancet       Date:  1986-04-12       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.